Biotia Launches Clinical Antimicrobial Resistance Reporting for UTIs

May 20, 2026
Biotia has introduced BIOTIA-DX Resistance, an antimicrobial resistance profiling tool now integrated into its CLEP-approved BIOTIA-ID Urine Test for clinical use across the U.S. The platform provides rapid resistance prediction to guide treatment for complicated urinary tract infections.

Biotia announced in a press release the clinical availability of its BIOTIA-DX Resistance technology, which is now part of the New York State CLEP-approved BIOTIA-ID Urine Test. The system provides rapid antimicrobial resistance profiling for patients with recurrent or complicated urinary tract infections.

The BIOTIA-ID Urine Test enables pathogen detection and resistance prediction directly from urine samples. It supports clinicians by providing actionable resistance data at diagnosis, allowing for more precise antibiotic selection and reduced use of broad-spectrum treatments.

Biotia's BIOTIA-DX Resistance tool achieved top performance in the 2026 CAMDA Antimicrobial Resistance Challenge, marking its second consecutive year as the highest scoring system. The competition benchmarks computational models for predicting resistance profiles using metagenomic data.

The technology is available for clinical use across all 50 U.S. states and is part of Biotia's broader diagnostic platform for infectious disease identification, combining curated genomic references with machine learning models to detect resistance across multiple organisms and drug classes.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

05/20
Araceli Biosciences Launches Endeavor Live Cell for Kinetic Imaging in Drug Discovery
05/20
Flywheel Integrates with AWS HealthImaging for Clinical and AI Data Management
05/20
NeuroDiscovery AI Launches NeuroTerminal Platform for Neurology Research
05/20
Open Medicine Introduces Living Algorithms for Oncology Decision Support
05/20
Novo Nordisk and Eli Lilly Dominate GLP-1 Mentions in AI Weight Loss Searches

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Trend report

Cybersecurity Trends Report 2025

Netwrix

The Cybersecurity Trends Report 2025 by Netwrix Research Lab provides insights into how organizations are adapting their cybersecurity strategies amidst growing AI adoption. The report, based on a survey of 2,150 IT professionals from 121 countries, highlights key trends such as the increase in hybrid IT environments, AI-driven security challenges, and the rising costs of security incidents.

Read more

You May Also Like